Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.42
+0.69 (2.17%)
At close: Nov 10, 2026, 4:00 PM EST
32.38
-0.04 (-0.12%)
After-hours: Nov 10, 2026, 4:10 PM EST
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.68 billion as of November 10, 2026. It is the 7,481st most valuable company in the world and the 1,908th biggest in the United States. Its market cap has decreased by 1.02% in one year.
Market Cap
1.68B
Enterprise Value
1.21B
1-Year Change
-1.02%
Global Rank
Country Rank
#1,908 United States
Category
ChartMarket Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.68B, a decrease of -6.71%. That is a compound annual growth rate of -1.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 1.68B | -4.47% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 1.70B |
| Kailera Therapeutics | 1.68B |
| Generate Biomedicines | 1.68B |
| Nurix Therapeutics | 1.67B |
| Precigen | 1.60B |
| Intellia Therapeutics | 1.59B |
| Ultragenyx Pharmaceutical | 1.57B |
| Nanobiotix | 1.53B |